Skip to content

    Breast Cancer Health Center

    Font Size
    A
    A
    A

    Blood Test Aims to Predict Breast Cancer's Return

    Study found DNA-based screen was more than 90 percent accurate in predicting recurrence

    WebMD News from HealthDay

    By Kathleen Doheny

    HealthDay Reporter

    TUESDAY, April 15, 2014 (HealthDay News) -- A new blood test may one day help predict the recurrence of breast cancer and also a woman's response to breast cancer treatment, researchers report.

    "We are able to do this with literally a spoonful of serum [blood]," said study co-author Saraswati Sukumar, who is co-director of the breast cancer program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, in Baltimore.

    Once a patient's blood is collected, the researchers isolate circulating tumor DNA. The genetics test then detects any of 10 breast cancer-specific genes that have undergone what experts call hypermethylation.

    In the hypermethylation process, the activity of some genes that keep cancers in check is turned off, and that may signal a return of the cancer.

    The new study is published April 15 in the journal Cancer Research.

    The test, called the cMethDNA, is at least five years from being available on the market, Sukumar predicted.

    Using this test, researchers could use the gene activity as an indication that the cancer had returned, and could also use it to see if treatments are working, Sukumar said. The blood test seems to indicate recurrences earlier than they could be found by imaging, she added.

    Other blood tests are on the market with the same aim, but are considered unreliable, said Sukumar and another breast cancer expert.

    Doctors typically rely on patient complaints, along with imaging studies, to determine if a cancer has returned after treatment.

    The new test was given to 55 healthy women and 57 who had breast cancer that had spread.

    "The test is able to detect [accurately] more than 90 percent of those who have recurrent cancer," Sukumar said. About 9 percent of cancer recurrences were misread as a negative result, she said.

    Dr. Joanne Mortimer, director of women's cancer programs at the City of Hope Comprehensive Cancer Center, in Duarte, Calif., said, "There is reason to be optimistic, and to study this further."

    However, Mortimer, who was not involved with the new research, said the study only included a small number of patients and more study is needed.

    "This is incredibly needed," she added, as other tests on the market aren't very reliable.

    According to Mortimer, the worst part of being treated for early stage breast cancer for patients is the period after treatment is over. "Then they live with this uncertainty. They may be cured, they may not. And only time will tell."

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
     
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
     
    Resolved To Quit Smoking
    VIDEO
    Breast Cancer Treatments Improving
    Article
     
    Woman getting mammogram
    Article
    Screening Tests for Women
    Article
     
    serious woman
    Article
    Pink badge on woman chest to support breat cancer
    QUIZ
     
    what is your cancer risk
    Article
    breast cancer survivors
    Article